Blue Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Blue Trust's EW Position: Q3 2026 in Review
Blue Trust reduced its Edwards Lifesciences (EW) stake by 34% in Q3 2026, selling an estimated $232K and leaving 5,001 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #524.
Blue Trust first reported a position in EW in Q2 2022 and has held it in 18 quarters since. The position peaked at $956K in Q4 2025. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Blue Trust held 5,001 shares of Edwards Lifesciences worth $432K as of Q3 2026.
- Blue Trust sold 2,616 Edwards Lifesciences shares in Q3 2026, an estimated $232K.
- Edwards Lifesciences made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #524 holding.
- Blue Trust first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Edwards Lifesciences position peaked at $956K in Q4 2025.
- 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.